In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Anna Fagotti, MD, PhD
Advertisement
Articles by Anna Fagotti, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tazemetostat Withdrawn From Follicular Lymphoma, Sarcoma Markets
2
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
3
Treating Young Patients With Colorectal Cancer: Talking With a Surgeon
4
Dismantling Barriers to Early Adoption of Bispecifics in Multiple Myeloma
5